Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Kenilworth, NJ.

BASF Plant Science is a subsidiary of BASF in which all plant biotechnology activities are consolidated. The GmbH was founded in 1998 and employs approximately 700 people at 6 different locations worldwide. The headquarters of BASF Plant Science is located in Research Triangle Park (North Carolina, USA). Plant Science has research sites in the US, Canada and Europe. At these locations the company is mainly developing genetically modified seeds.

Liuzhou Gengqing Technology Co., Ltd., established on 2014-11-27, The scope of business includes the research and experimental development of green seedlings and flowers,Cultivation and sales;Aquatic product sales;Gardening production and sales;Import and export trade of green seedlings and flowers;Forest tree seeds(urban green seedlings,flowers)Production and Wholesale(Limited to branch operations).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Liuzhou Tianzi Gardening Co., Ltd., established on 2010-09-13, The business scope includes the cultivation and sales of landscaping seedlings and flowers,Research and development of nursery stock and flower technology,Aquatic product sales;Gardening production and sales;Import and export trade of green seedlings and flowers.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Nippon Kayaku produces and retails a range of chemicals. By product category, the company divides itself into four areas. Epoxy resins used as flame retardants in electronics, colorants, and dyes used in inkjet printers and materials for the production of textiles are sold by the functional chemicals segment, which is the one that generates the most income of any segment. Pharmaceutical companies market anti-cancer, biological, cardiovascular, vitamin, and anti-inflammatory medications. The automotive sector is supplied by the safety systems segment with airbag inflators and micro gas generators for seatbelt pre-tensioners, both of which are intended to protect passengers in the event of an accident. Insecticides and herbicides are offered for sale in the agrochemicals market.

Sumitomo Chemical Co. Ltd. is a Japanese company that produces and markets various types of chemicals. The company’s business sectors include petrochemicals and plastics, energy and functional materials, IT-related chemicals, health and crop sciences, and pharmaceuticals. Its portfolio of products includes propylene oxide, caprolactam, polypropylene, polyethylene, methyl methacrylate polymer, alumina, aluminum, resorcinol, synthetic rubber, polarizing films, photoresists, super engineering plastics, lithium-ion secondary battery materials, crop protection chemicals, feed additives, products for control of infectious diseases, and more. The firm manages two companies in the pharmaceutical sector: Sumitomo Dainippon Pharma Co., Ltd., engaged in the prescription pharmaceuticals business; and Nihon Medi-Physics Co., Ltd., engaged in the diagnostic pharmaceuticals business. Sumitomo Chemical Co. Ltd. was founded in 1913 and is headquartered in Tokyo, Japan.

Shaanxi Lvke Biotechnology Co., Ltd., established on 2015-06-10, Business scope includes licensed business items:fertilizer production;production of pesticides;(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)General operating items:Fertilizer R&D,Sales and technical service,technology development,technology transfer;Agricultural Technical Services;Chemical Products(non-hazardous,monitor,precursor chemicals)research and development,Production,Sales;pesticide(Free of hazardous chemicals and rodenticides)research and development,Sales;Sales of agricultural and sideline products.(The above business scope excludes the special control and pre-licensing projects stipulated by the state)

BTG acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications. This segment also provides interventional vascular products consisting of EKOS system, an ultrasonic catheter drug delivery device used in the treatment of blood clots; Varithena for the treatment of varicose veins; and PneumRx Coil for the treatment of emphysema, a debilitating lung disease. The Pharmaceuticals segment offers antidote products, such as CroFab for the treatment of crotalid snake envenomations; DigiFab for the treatment of digoxin toxicity; and Voraxaze for high-dose methotrexate toxicity. The Licensing segment provides Zytiga for treatment of prostate cancer; Two-Part Hip Cup; and Lemtrada. The company also manufactures and commercializes therapeutic ultrasound devices, and roxwood systems, as well as develops venous thrombus management devices. British Technology Group International that began operation in 1948 became BTG in March 1995. Its headquarters is in London in the United Kingdom.

Green Cross Corp. engages in the manufacture and sale of pharmaceutical products. Its products include medicines for blood, over the counter drugs, generals, vaccines, and others. The company was founded on November 1, 1969 and is headquartered in Yongin, South Korea.

A. Nattermann & Cie. GmbH engages in the production of over-the-counter and consumer health care drugs. Its products are sold to distribution firms of the Sanofi group. The company is headquartered in Cologne, Germany.

Hebei Hebei Microbial Technology Co., Ltd., established on 2002-04-26, Business scope includes general items:development of biotechnology,transfer,consult,Serve;Soil Pollution Control and Restoration Services;Research and development of harmless treatment technology for agricultural organic waste,Promotion and related technical services;Specialty Chemicals Sales(Free of Hazardous Chemicals).licensed items:bio organic fertilizer,Agricultural microbial agent,Research and development of organic material decomposing agent and related products,Production,Sales;Development of biopesticides;pesticide,Potassium dihydrogen phosphate,Foliar fertilizer,Sales of water-soluble fertilizers.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Qingdao Yuanzhilin Agricultural Technology Development Co., Ltd., established on 2014-07-01, The business scope includes agricultural products,feed,pesticide,fertilizer,Healthy food,traditional Chinese medicine,Research and development of crop seed technology(Does not include production). (Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Green Cross Co., Ltd. engages in the manufacture, sale, and rental of safety items. Its products include road safety materials, disaster prevention necessities, safety equipment, protection gear, and signboards and tags. The company was founded in January 1969 and is headquartered in Fukuoka, Japan.

Beijing Anjianxi Pharmaceutical Technology Co., Ltd., established on 2016-10-28, Business scope includes technology development,Technology Promotion,technology transfer,technical consulting,Technical Services;Sell ​​self-developed products;Agricultural Science Research and Experimental Development;Medical Research and Experimental Development.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Tsumura & Co. engages in the manufacture and sale of pharmaceutical products. It manufactures and sells Kampo medicine, a traditional form of medicine in Japan. It is also involved in the procurement, production, processing, and storage of botanical raw materials; production and sale of Kampo extract intermediates; and provision of logistics, storage, distribution, and materials handling services. Its products include Chujoto, L'amour, Tsumura-Kampo Kakkonto, Tsumura-Kampo Otsujito, and Tsumura-Kampo Orengedokuto. The company was founded by Jusha Tsumura on April 10, 1893 and is headquartered in Tokyo, Japan.

Guangxi Longzhou Beibu Gulf Modern Agriculture Co., Ltd., established on 2015-11-13, The business scope includes edible fungi,fruit,vegetable planting,Sales;livestock farming,Sales;Agricultural straw,Skin,shell processing,Sales;Import and export of goods and technology;iron shed production;storage(Removal of hazardous chemicals);Sales:Edible fungi,Fungus stick,seedlings,fertilizer,feed,Agricultural and sideline products,furniture,building materials,Equipment,plastic products,Wujinjiaodian,knitted products,Daily necessities,household appliances;Foam manufacturing(Excluding the country's prohibition on investing in new production lines),Sales;Ordinary road freight transport;food manufacturing,Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Meiji Seika Pharma Co., Ltd. engages in the business of manufacture and distribution of pharmaceutical products. It also engages in the animal health business. The company was founded on October 9, 1916 and is headquartered in Tokyo, Japan.

Zeria Pharmaceutical produces veterinary pharmaceuticals, agricultural chemicals, industrial chemicals and reagents, and more. In addition, they also provide cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, and more.

NicOx is a biopharmaceutical company, engages in the development and commercialization of nitric oxide (NO)-donating drugs primarily for inflammation and cardio-metabolic diseases. The company's primary products candidates include Naproxcinod, a Phase III product candidate for the treatment of osteoarthritis; and NCX 6560, a NO-donating compound for the treatment of cardiovascular diseases, which is in phase I clinical trials. Its product portfolio comprise PF-03187207 for the treatment of glaucoma, TPI 1020 for the treatment of respiratory disorders, and NCX 1510 for allergic rhinitis, which are in Phase II clinical trials; and NO-donating antihypertensives, which is in phase I clinical trials for the treatment of hypertension. The company's product pipeline also include NCX 1047, which is in preclinical stage of development for treating a range of skin disorders, such as atopic dermatitis, psoriasis, and seborrheic dermatitis; and NO-donors for diabetic retinopathy, cardiometabolic, inflammation, and pain. It has research and co-development agreement with Orexo AB to identify and develop compounds for the treatment of airway diseases; license and development agreement with TOPIGEN Pharmaceuticals Inc. The company also has agreements with Grupo Ferrer Internacional SA for the research, development, and marketing of NO-donating anti-inflammatory drugs for the treatment of dermatological diseases; Pfizer Inc to identify nitric oxide-donating compounds for diabetic retinopathy; and Merck & Co., for the development of new antihypertensive drugs using NicOx' nitric oxide-donating technology. NicOx S.A. was founded in 1996 and is headquartered in Sophia Antipolis, France.

Chengdu Holy Spirit Biotechnology Co., Ltd., established on 2013-06-24, Business scope includes research and development of edible fungi;Cultivation and sales of edible mushrooms.retail:Pre-packaged food(Operating with a food distribution license,Valid until2016year6moon18day).